| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |